Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 08, 2021 09:00 ET | Source: Delcath Systems, Inc.

Delcath Systems to Participate at Upcoming Virtual Investor Conferences

NEW YORK, March 08, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
February 11, 2021 09:00 ET | Source: Delcath Systems, Inc.

Delcath Systems to Participate at Upcoming Virtual Investor Conferences

NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
January 11, 2021 10:56 ET | Source: Delcath Systems, Inc.

Delcath Systems to Present at the H.C. Wainwright Virtual BioConnect Conference

NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH ), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
December 11, 2020 10:31 ET | Source: Delcath Systems, Inc.

Delcath Systems Announces Completion of Underwritten Public Offering

NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
December 09, 2020 08:00 ET | Source: Delcath Systems, Inc.

Delcath Systems Announces Pricing of Public Offering of Common Stock

NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
December 08, 2020 16:01 ET | Source: Delcath Systems, Inc.

Delcath Systems Announces Proposed Public Offering of Common Stock

NEW YORK, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
December 07, 2020 07:30 ET | Source: Delcath Systems, Inc.

Kevin Muir Joins Delcath Systems, Inc. as VP, Commercial Operations

NEW YORK, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today...
November 11, 2020 08:00 ET | Source: Delcath Systems, Inc.

Delcath Systems, Inc. Announces Third Quarter 2020 Results

NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today...
November 02, 2020 16:01 ET | Source: Delcath Systems, Inc.

Delcath Systems, Inc. to Participate in Oppenheimer Fall MedTech Summit on Thursday, November 12, 2020

NEW YORK, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on liver-directed treatment of primary and metastatic cancers, today...
November 02, 2020 09:00 ET | Source: Delcath Systems, Inc.

Delcath Schedules Conference Call to Report 2020 Third Quarter Financial Results

NEW YORK, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on liver-directed treatment of primary and metastatic cancers, today...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right